NCT03106545View on ClinicalTrials.gov

Liposome Bupivacaine for ANKLE Blocks

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 2, 2017

Primary Completion Date

June 26, 2017

Study Completion Date

October 31, 2017

Conditions
Hallux Valgus (Bunions)
Interventions
DRUG

Liposome bupivacaine

Trial Locations (1)

B-3600

Ziekenhuis Oost-Limburg, Genk

Sponsors
All Listed Sponsors
collaborator

Pacira Pharmaceuticals, Inc

INDUSTRY

lead

Catherine Vandepitte, M.D.

OTHER

NCT03106545 - Liposome Bupivacaine for ANKLE Blocks | Biotech Hunter | Biotech Hunter